ArticleFrontiers in oncology2025

Effective vemurafenib monotherapy for refractory Langerhans cell histiocytosis with sustained results post-withdrawal for over two years: a case report.

Jiaxin Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.